Clinical Trial Update: Efficacy of Montelukast on STEMl Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating montelukast for patients with ST-segment elevation myocardial infarction and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Myocardial Infarction (MI) | Phase 3 | Status: RECRUITING